DANIELLE KWAKYE-BERKO: Open Payments
NPI 1821060583 · HENDERSON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,084 in 59 payments from 15 companies in 2025. Trend: 2023 $174 · 2024 $1,532 · 2025 $1,084
Food & beverage: $1,084
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 13 | $240 |
| PFIZER INC. | 9 | $170 |
| GlaxoSmithKline, LLC. | 9 | $153 |
| Teva Pharmaceuticals USA, Inc. | 5 | $101 |
| ABBVIE INC. | 5 | $89 |
| Lilly USA, LLC | 4 | $65 |
| Corcept Therapeutics | 2 | $54 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $53 |
| Dexcom, Inc. | 2 | $42 |
| Merck Sharp & Dohme LLC | 2 | $30 |
Products named: NURTEC ODT, TRELEGY ELLIPTA, UZEDY, Ozempic, VRAYLAR, Wegovy, MOUNJARO, Rybelsus.
Industry payments across NC — which companies pay providers there.
